Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Incos AB in connection with the sale of Scandinanvian Cosmetics AB
Mandate

Vinge advises Incos AB in connection with the sale of Scandinanvian Cosmetics AB

June 22, 2011

Vinge has advised the seller, Incos AB, in connection with the sale of Scandinavian Cosmetics AB together with its wholly owned subsidiary, BeautyCos AB, to the Valoras Group, which is listed in Switzerland.

Scandinavian Cosmetics AB and BeautyCos AB are Sweden's leading distributors of cosmetics, fragrances, skincare and haircare products. The companies market approximately 40 world leading trademarks within the beauty industry. The product portfolio includes Max Factor, Olay, Clarins, Kanebo/Sensai, Hugo Boss, Lacoste, Puma, Gucci, Escada, Bvlgari and Björn Axén. The companies have approximately 100 employees at offices in Malmö and Stockholm. In May this year, Scandinavian Cosmetics was awarded "Entrepreneur Company (South) 2011".

Vinge was the sole adviser and project manager in respect of the entire transaction. Vinge's team consisted of, among others, client relationship partner Lars Gildés and associates Christian Lindhé and Karolina Tjärnberg.

Related

Vinge advises Revivo Group on the acquisition of IdeaPaint

 Revivo Group is continuing its expansion in Finland through the acquisition of IdeaPaint Oy, a Tampere-based company specialising in industrial surface treatment.
September 21, 2026

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

 Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026